/ACTG

Acacia Research Corp

ACTG

$4.57USD↑+0.00%+0.00 today

MARKET CAP

446.0M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$5 – $5

52W RANGE

$3

$5

AI Summary

Stalk

TrimMedium

ACTG remains in a Stage 4 decline with a medium-term bearish bias reinforced by the Bearish Pivot Point pattern and lower highs under the 50-day SMA. Short-term conditions are neutral, as price holds just below flattening 9/20/50 EMAs without clear momentum. We will look to sell into rebounds toward those EMAs and the 50-day SMA, aiming for rejection-based entries. The long-term uptrend above the 200-day SMA persists, providing structural support but not overriding current downtrend pressures.

↑Q2 revenue $114.6M (+124% YoY) driven by acquisitions
↑$334.6M cash on hand, no parent debt enables opportunistic M&A
↓Licensing rev variability; $3.7M legal costs strain cash flow

Full analysis →

Buying

4

institutions

Selling

3

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	2.60 M	12.10 M	+190.91 K	+4.6%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	1.42 M	6.59 M	+7.50 K	-2.6%	0.01%
CA Citadel Advisors LLC Q2 2026	BUY	249.52 K	1.16 M	+16.65 K	+3.8%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	236.39 K	1.10 M	+154.68 K	+180.3%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	89.57 K	417.40 K	+-26.29 K	-25.6%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	42.41 K	197.63 K	+-46.14 K	-53.6%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-40.04 K	-100.0%	0.00%